Does HIV-1 subtype influence genotypic changes associated with anti-retroviral failure

被引：0
|
作者：
Ushiro-Lumb, I
Norman, J
Skinner, C
Murphy, M
Breuer, J
Aitken, C
机构：
[1] Barts & London NHS Trust, Dept Virol, London, England
[2] Barts & London NHS Trust, Dept Infect & Immun, London, England
来源：
AIDS | 2000年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P359
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [21] Correlation between genotypic evidence of HIV-1 resistance to the protease inhibitor MK-639 and loss of anti-retroviral effect in treated patients
    Mellors, JW
    McMahon, DK
    Chodakewitz, JA
    Schleif, WA
    Emini, EA
    Condra, JH
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 71 - 71
  • [22] Genotypic prediction of HIV-1 subtype D tropism
    Stéphanie Raymond
    Pierre Delobel
    Marie-Laure Chaix
    Michelle Cazabat
    Stéphanie Encinas
    Patrick Bruel
    Karine Sandres-Sauné
    Bruno Marchou
    Patrice Massip
    Jacques Izopet
    Retrovirology, 8
  • [23] Genotypic prediction of HIV-1 subtype D tropism
    Raymond, Stephanie
    Delobel, Pierre
    Chaix, Marie-Laure
    Cazabat, Michelle
    Encinas, Stephanie
    Bruel, Patrick
    Sandres-Saune, Karine
    Marchou, Bruno
    Massip, Patrice
    Izopet, Jacques
    RETROVIROLOGY, 2011, 8
  • [24] Can interruption/withdrawl of anti-retroviral therapy provide personalized immunotherapy against HIV-1?
    Bretscher, Peter A.
    Al-Yassin, Ghassan
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (06)
  • [25] Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy
    Al-Mawsawi, Laith Q.
    Neamati, Nouri
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (10) : 526 - 535
  • [26] Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
    Mark E. Sharkey
    Ian Teo
    Thomas Greenough
    Natalia Sharova
    Katherine Luzuriaga
    John L. Sullivan
    R. Pat Bucy
    Leondios G. Kostrikis
    Ashley Haase
    Claire Veryard
    Raul E. Davaro
    Sarah H. Cheeseman
    Jennifer S. Daly
    Carol Bova
    Richard T. Ellison
    Brian Mady
    Kwan Kew Lai
    Graeme Moyle
    Mark Nelson
    Brian Gazzard
    Sunil Shaunak
    Mario Stevenson
    Nature Medicine, 2000, 6 : 76 - 81
  • [27] Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
    Sharkey, ME
    Teo, I
    Greenough, T
    Sharova, N
    Luzuriaga, K
    Sullivan, JL
    Bucy, RP
    Kostrikis, LG
    Haase, A
    Veryard, C
    Davaro, RE
    Cheeseman, SH
    Daly, JS
    Bova, C
    Ellison, RT
    Mady, B
    Lai, KK
    Moyle, G
    Nelson, M
    Gazzard, B
    Shaunak, S
    Stevenson, M
    NATURE MEDICINE, 2000, 6 (01) : 76 - 81
  • [28] The reverse transcriptase of HIV-1: role of the domain connection and RNase H in anti-retroviral resistors
    Roquebert, Benedicte
    Leleu, Juliette
    VIROLOGIE, 2010, 14 (02) : 129 - 139
  • [29] The efficacy of potent anti-retroviral drug combinations tested in a murine model of HIV-1 encephalitis
    Limoges, J
    Poluektova, L
    Ratanasuwan, W
    Rasmussen, J
    Zelivyanskaya, M
    McClernon, DR
    Lanier, ER
    Gendelman, HE
    Persidsky, Y
    VIROLOGY, 2001, 281 (01) : 21 - 34
  • [30] The evolution of HIV-1 subtypes and disease progression among adults on anti-retroviral drugs in Northern Tanzania
    E Shao
    B Nyombi
    J Sabuni
    Retrovirology, 9
12345